Sign in

CIK 0001719406 · Non-accelerated filer<br>Smaller reporting company

NRX Pharmaceuticals, Inc.

Sign in to watch
Ticker
NRXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
822844431
Phone
484-254-6134
Business address
1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, 19801
Former names
Big Rock Partners Acquisition Corp.
  1. 3 Insider Initial Statement of Ownership
  2. 8-K Event Material agreement · Executive or director change
  3. 8-K Event Results of operations · Regulation FD disclosure
  4. 10-Q Report Quarterly Report
  5. S-1 Offering Registration Statement
  6. 8-K Event Other events
  7. 8-K Event Material agreement · New debt or obligation · Unregistered share sale
  8. 8-K Event Executive or director change · Shareholder vote results · Regulation FD disclosure
  9. DEF 14A Proxy Proxy Statement
  10. PRE 14A Proxy Proxy Statement (Preliminary)
  11. 8-K Event Executive or director change · Other events
  12. 424B3 Offering Prospectus
  13. 8-K Event Results of operations
  14. 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Bylaws or fiscal year change · Other events
  15. 10-Q Report Quarterly Report
  16. 424B3 Offering Prospectus
  17. 8-K Event Delisting notice · Other events
  18. 424B3 Offering Prospectus
  19. 8-K Event Agreement ended · Other events
  20. 3 Insider Initial Statement of Ownership

Page 5 of 24 · 479 filings